Heavenly Health Care | |
1506 E Griffin Parkway Ste B, Mission, Texas 78572 | |
(956) 271-4755 | |
Not Available |
Name | Heavenly Health Care |
---|---|
Location | 1506 E Griffin Parkway Ste B, Mission, Texas |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 679656 |
Ownership Type | Proprietary |
Service Area Zip Codes | 78501, 78539, 78572, 78573, 78576, 78577, 78582, 78595, 78596 |
NPI Number | 1881628337 |
Organization Name | HEAVENLY HEALTH CARE, LLC |
Address | 1506 E Griffin Pkwy Ste B, Mission, TX 78572 |
Phone Number | 956-271-4755 |
News Archive
Researchers at Rosalind Franklin University of Medicine and Science have induced empathy-like behavior by identifying then manipulating a brain circuit in an experimental model, an indication that new strategies may help people with autism spectrum disorder gain social abilities.
In a Huffington Post opinion piece, Gro Brundtland, a member of the U.N. Foundation board of directors, former WHO director general and former prime minister of Norway, discusses global progress on childhood vaccines. Brundtland discusses the upcoming launch of the U.N. Foundation's global vaccines campaign aimed at inspiring Americans "to provide children in the developing world with immunizations against deadly diseases."
In a new study published online today by Clinical Therapeutics, researchers from Adheris, Inc., an inVentiv Health company, found that patients new to chronic disease medication face the greatest risk of medication discontinuation during the first 30 days of treatment—with rates of discontinuation ranging from 29.6% to 78.1%.
Vaxart, Inc., a San Francisco biotechnology company developing oral-delivery vaccines, has closed a $12.5 million Series B financing, led by Care Capital of Princeton NJ. The funding will be used to advance the Company's lead product, an oral vaccine for Avian influenza, through Phase I clinical trials.
› Verified 4 days ago
Quality Rating: | Not Available* |
* The number of patient episodes for this measure is too small to report. |
News Archive
Researchers at Rosalind Franklin University of Medicine and Science have induced empathy-like behavior by identifying then manipulating a brain circuit in an experimental model, an indication that new strategies may help people with autism spectrum disorder gain social abilities.
In a Huffington Post opinion piece, Gro Brundtland, a member of the U.N. Foundation board of directors, former WHO director general and former prime minister of Norway, discusses global progress on childhood vaccines. Brundtland discusses the upcoming launch of the U.N. Foundation's global vaccines campaign aimed at inspiring Americans "to provide children in the developing world with immunizations against deadly diseases."
In a new study published online today by Clinical Therapeutics, researchers from Adheris, Inc., an inVentiv Health company, found that patients new to chronic disease medication face the greatest risk of medication discontinuation during the first 30 days of treatment—with rates of discontinuation ranging from 29.6% to 78.1%.
Vaxart, Inc., a San Francisco biotechnology company developing oral-delivery vaccines, has closed a $12.5 million Series B financing, led by Care Capital of Princeton NJ. The funding will be used to advance the Company's lead product, an oral vaccine for Avian influenza, through Phase I clinical trials.
› Verified 4 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | Not Available |
Health team communicated well with them | Not Available |
Health team discussed medicines, pain, and home safety | Not Available |
How patients rated overall care from agency | Not Available |
News Archive
Researchers at Rosalind Franklin University of Medicine and Science have induced empathy-like behavior by identifying then manipulating a brain circuit in an experimental model, an indication that new strategies may help people with autism spectrum disorder gain social abilities.
In a Huffington Post opinion piece, Gro Brundtland, a member of the U.N. Foundation board of directors, former WHO director general and former prime minister of Norway, discusses global progress on childhood vaccines. Brundtland discusses the upcoming launch of the U.N. Foundation's global vaccines campaign aimed at inspiring Americans "to provide children in the developing world with immunizations against deadly diseases."
In a new study published online today by Clinical Therapeutics, researchers from Adheris, Inc., an inVentiv Health company, found that patients new to chronic disease medication face the greatest risk of medication discontinuation during the first 30 days of treatment—with rates of discontinuation ranging from 29.6% to 78.1%.
Vaxart, Inc., a San Francisco biotechnology company developing oral-delivery vaccines, has closed a $12.5 million Series B financing, led by Care Capital of Princeton NJ. The funding will be used to advance the Company's lead product, an oral vaccine for Avian influenza, through Phase I clinical trials.
› Verified 4 days ago
The patient survey data of Heavenly Health Care is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 90 | 88 |
Percent of patients who reported that their home health team communicated well with them | 90 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 95 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 94 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 95 | 78 |
News Archive
Researchers at Rosalind Franklin University of Medicine and Science have induced empathy-like behavior by identifying then manipulating a brain circuit in an experimental model, an indication that new strategies may help people with autism spectrum disorder gain social abilities.
In a Huffington Post opinion piece, Gro Brundtland, a member of the U.N. Foundation board of directors, former WHO director general and former prime minister of Norway, discusses global progress on childhood vaccines. Brundtland discusses the upcoming launch of the U.N. Foundation's global vaccines campaign aimed at inspiring Americans "to provide children in the developing world with immunizations against deadly diseases."
In a new study published online today by Clinical Therapeutics, researchers from Adheris, Inc., an inVentiv Health company, found that patients new to chronic disease medication face the greatest risk of medication discontinuation during the first 30 days of treatment—with rates of discontinuation ranging from 29.6% to 78.1%.
Vaxart, Inc., a San Francisco biotechnology company developing oral-delivery vaccines, has closed a $12.5 million Series B financing, led by Care Capital of Princeton NJ. The funding will be used to advance the Company's lead product, an oral vaccine for Avian influenza, through Phase I clinical trials.
› Verified 4 days ago
Angelitos Home Health Care Inc Location: 704 E Griffin Parkway Suite 120, Mission, Texas 78572 Ratings: Phone: (956) 584-2410 | |
Dedication Of Care Home Health Agency Location: 1904 E. Griffin Parkway Ste B., Mission, Texas 78572 Ratings: Phone: (956) 316-3627 | |
Step By Step Home Health Care Location: 909 Business Park Drive Ste 10, Mission, Texas 78572 Ratings: Phone: (956) 961-4288 | |
Arise Home Health Care Inc Location: 215 Catholic War Veterans Blvd., Mission, Texas 78572 Ratings: Phone: (956) 580-1155 | |
New Era Medical Services Inc Location: 2121 E Griffin Parkway Suite 7, Mission, Texas 78572 Ratings: NA Phone: (956) 928-0609 |